Medicare To Cover "Routine Care Costs" Of Private And Public Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration intends to allow Medicare coverage "of routine care costs" for all device trials conducted under IDEs, provided they fall within statutory benefits, according to the agency.
You may also be interested in...
Unique Missions Of FDA, CMS Underscored In Presentations To HHS Panel
Ongoing attempts to coordinate FDA and CMS reviews will preserve approval, coverage, coding and payment as distinct processes, agency representatives concurred at the HHS Secretary's Advisory Committee on Regulatory Reform regional hearing June 10
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.